**COMPANY REGISTRATION NUMBER: 09176062 CHARITY REGISTRATION NUMBER: 1160693** 

## **The Brazzaville Foundation Company Limited by Guarantee Unaudited Financial Statements** 

## **31 December 2025** 

**Hopper Williams & Bell Limited Highland House, Mayflower Close Chandlers Ford, Eastleigh Hampshire SO53 4AR** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Financial Statements** 

## **Year ended 31 December 2025** 

||**Page**|
|---|---|
|Trustees' annual report (incorporating the director's report)|**1**|
|Independent examiners report to the members|**12**|
|Statement of financial activities (including income and||
|expenditure account)|**14**|
|Statement of financial position|**15**|
|Statement of cash flows|**16**|
|Notes to the financial statements|**19**|





## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Trustees' Annual Report (Incorporating the Director's Report)** 

## **Year ended 31 December 2025** 

The trustees, who are also the directors for the purposes of company law, present their report and the financial statements of the charity for the year ended 31 December 2025. 

## **Reference and administrative details** 

|**Registered charity name**|The Brazzaville Foundation|
|---|---|
|**Charity registration number**|1160693|
|**Company registration number**|09176062|
|**Registered office**|36/37 Vintage House|
||Albert Embankment|
||London|
||SE1 7TL|
|**The trustees**|Mr Jean-Yves Ollivier|
||Mr Kishore Sakhrani|
||Mrs Martine Chayrigues|
||Mr Philippe Jonnart|
||Mr Olivier Armand|
||Prof. Francois Tron|
|**Independent Examiner**|Hopper Williams & Bell Limited|
||Highland House, Mayflower Close|
||Chandlers Ford, Eastleigh|
||Hampshire|
||SO53 4AR|
|**Bankers**|International Business Bank Togo|
||169 Boulevard du 13 Janvier|
||BP 363 Lome|
||Republic of Togo|
||M2 3AZ|
||Metro Bank PLC|
||One Southampton Row|
||London|
||WC1B 5HA|
|**Solicitors**|Bates Wells Braithwaite|
||10 Queen Street Place|
||London|
||EC4R 1BE|



**1** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Trustees' Annual Report (Incorporating the Director's Report)** _**(continued)**_ 

## **Year ended 31 December 2025** 

## **Structure, governance and management** 

The Foundation is an independent, non-profit organisation based in London. It takes its name and inspiration from the Brazzaville Protocol, signed in 1988 in the Congolese capital. A key moment in the history of modern Africa, this was an example of negotiations led by Africans themselves, leading to the peaceful resolution of conflicts in Southern Africa. They paved the way for Nelson Mandela's release, Namibia's independence, and the end of Apartheid. 

This annual report covers the year from 1 January to 31 December 2025. 

## Legal Objects 

The Foundation was formed as a Company limited by Guarantee incorporated on 14 August 2014 with company number 09176062.  The Company was registered as a charity with the Charity Commission on 27 February 2015 with charity number 1160693. The name of the Foundation was changed from the Brazzaville Foundation for Peace and Conservation to The Brazzaville Foundation by a Special Resolution dated 22 November 2018. The Articles of Association, as amended by Special Resolutions dated 18 February 2015 and 22 November 2018, define the company as being restricted specifically to: 

 " the promotion of national and international conflict resolution and reconciliation for the public benefit with a view to relieving suffering and poverty and promoting human rights and religious and racial harmony by mediating with parties to the conflict and others together to discuss possible solutions”; 

 " the saving of lives, the advancement of health, the relief of need, and the preservation and conservation for the public benefit of the physical and natural environment including landscapes, flora and fauna and the furtherance of other purposes recognised as charitable under English law, in particular (but without limitation) in areas affected by conflict around the world, and provided that all activities shall be balanced and shall maintain or enhance the charity's commitment to remaining independent and impartial. 

**2** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Trustees' Annual Report (Incorporating the Director's Report)** _**(continued)**_ 

## **Year ended 31 December 2025** 

**Structure, governance and management** _**(continued)**_ 

Royal Patron 

From the commencement, HRH Prince Michael of Kent has been the patron of the Foundation and has devoted considerable time to its activities. 

Trustees, Governance and Administration 

The Articles of Association provide that there should be at least three Trustees who shall serve for a renewable term of three years. The Trustees, who are also directors of the company, are not remunerated for their trusteeship and details of Trustee expenses and any related party transactions are disclosed in the notes to the accounts. 

The Board of Trustees' main role is to ensure that the Foundation's vision and mission are properly fulfilled through the establishment of appropriate long-term and annual strategic plans and the proper implementation of these strategic plans. It is chaired by Mr Jean-Yves Ollivier, who has been engaged in conflict resolution in Africa for more than thirty-five years and supported by an experienced international Advisory Board. The other trustees are Mrs Martine Chayrigues (France), Mr Kishore Sakhrani (Hong Kong), Mr Philippe Jonnart also Treasurer (Switzerland), Mr Olivier Armand (Belgium) and Prof François Tron (France). 

Administering the day-to-day operation of the charity and its staff is Mr Foulo Basse who holds the position of Chief Executive. 

The Foundation is committed to maintaining the highest standards of integrity and ethical behaviour in all its activities. All those working for the Foundation or associated with it are expected to uphold those standards. 

**3** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Trustees' Annual Report (Incorporating the Director's Report)** _**(continued)**_ 

## **Year ended 31 December 2025** 

**Structure, governance and management** _**(continued)**_ 

## Advisory Board 

The Foundation has established a board of advisors made up of distinguished individuals whose experience and expertise in different fields enable them to give guidance to the Foundation and assist it in its work. The Advisory Board members play no role in the governance of the charity nor in its administration. 

The Advisory Board members are: 

- ✓ Chief Olusegun Obasanjo, former President of Nigeria; 

- ✓ Hon. Kgalema Motlanthe, former President of South Africa; 

- ✓ Dr Joyce Banda, former President of Malawi; 

- ✓ Hon. Kabine Komara, former Prime Minister of Guinea; 

- ✓ Hon. Amama Mbabazi, former Prime Minister of Uganda; 

- ✓ Dr Nakedi Mathews Phosa, a leading member and former Treasurer General of the ANC in South Africa; 

- ✓ Pär Stenbäck, former Secretary General of the International Federation of Red Cross and Red Crescent Societies; 

- ✓ Jan Kohout, former Foreign Minister of the Czech Republic; 

- ✓ Jean-Louis Bruguière, former French counter-terrorist judge; 

- ✓ Ilmas Futehally, Executive Director of the Strategic Foresight Group; 

- ✓ HSH Prince Philipp of Liechtenstein, Chairman of the LGT Group 

- ✓ Dr Sundeep Waslekar, President of the Strategic Foresight Group. 

- ✓ Dr Zinhle Mandela-Dlamini, Director of Newshelf 1186 and Newshelf 1198, South Africa 

- ✓ Prof Moustafa Mijiyawa, former Minister of Health, Togo 

- ✓ Najib Gouiaa, Chief Executive Officer at MediaCity, Mauritius 

- ✓ Alessandra Morelli, Former delegate of the United Nations Refugee Agency 

2025 Appointment of Adisory Board members: 

- ✓ Hon. Sidiki Kaba, former Prime Minister of Senegal 

- ✓ Karima Mkika, President of the AI Karam Association 

- ✓ Hatice Beton, Co-Founder and Executive Director of the G20 & G7 Health and Development Partnership 

**4** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Trustees' Annual Report (Incorporating the Director's Report)** _**(continued)**_ 

## **Year ended 31 December 2025** 

## **Structure, governance and management** _**(continued)**_ 

## Risk Management 

The Trustees have a risk management strategy which includes annual review of the risks to which the charity is exposed, and the establishment and implementation of systems and procedures designed to mitigate the impact on the charity of the risks identified. Key elements of the strategy include: 

- The implementation of procedures for the authorisation of all financial transactions and the 

- incurring of financial obligations; 

- The setting of a reserves policy and its regular review by the Trustees; 

- The agreement of an annual budget which is regularly reviewed; 

- The regular monitoring of geostrategic and geopolitical risks related to operating in African 

- countries and the consideration of the impact of the media and the effect on the Foundation's reputation. 

The Foundation endeavours to constantly improve its financial, budgetary and accounting management tools. 

## **Objectives and activities** 

## Mission Statement 

The Brazzaville Foundation promotes and supports African initiatives. Its vision for the future is to enable African leadership in all sectors in which it can be exercised (public, private, civil society), with a view to contributing to African solutions to the challenges facing the continent. The Foundation supports leaders (opinion and decision-makers, influencers, groups or individuals) who share its vision and mission. The work programmes are designed to support the African Union's Agenda 2063 and the achievement of the United Nations Sustainable Development Goals (SDGs). 

The Brazzaville Foundation aims to find African solutions to the major challenges of the continent and give them a long-lasting impact in the following areas of work: 

- Peace - facilitating the intra-Libyan dialogue and resolving international conflicts; 

- Environment - preserving the planet's second lung, the Congo basin; 

- Health - fostering access to quality medicines and fighting against medicines that kill and 

- Foresight - building a new approach to democratic governance and supporting young African talent. 

The Trustees have paid due regard to the duty in Section 17(5) of the Charities Act 2011, to have regard to the Public Benefit guidance published by the Charity Commission in deciding what activities to undertake. 

**5** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Trustees' Annual Report (Incorporating the Director's Report)** _**(continued)**_ 

## **Year ended 31 December 2025** 

## **Programme of work for the year 2025** 

Since its creation, the Brazzaville Foundation has contributed to the design, promotion and support of African solutions to the major challenges facing Africa in the areas of peace, environment and health. 

Throughout the year ended 31 December 2025, the Foundation has worked on a wide range of issues and launched several major initiatives: 

## **National parliamentary engagement – Togo** 

A seminar was organised at the National Assembly of Togo, bringing together members of parliament and health authorities to present the issue of falsified medicines, explain the risks to the population, and strengthen political support for the national plan currently under development. 

## **Interministerial technical work – Togo** 

A meeting of the National Technical Committee was co-hosted by the Togolese Ministry of Health and the Brazzaville Foundation. It focused on the operational preparation of the national plan, including pharmaceutical regulation, quality control, digitalisation of procedures, and training of health personnel. 

## **Health and Wellness Fair – Togo** 

`o` Panel on combating falsified medicines. 

The first edition of the country’s Health and Wellness Fair was organised by Togo and the national pharmaceutical sector, in close collaboration with the Brazzaville Foundation. On this occasion, the Foundation and the Ministry of Health co-hosted a major panel dedicated to the fight against falsified medicines. 

`o` Public awareness. Coverage on the national television news helped extend the reach of prevention messages to the broader population. 

## **7th Meeting of the AUDA-NEPAD Steering Committee (African Union Development Agency) – Senegal** 

From 15 to 17 September 2025 in Dakar, the Brazzaville Foundation took part in the 7[th] meeting of the AUDA-NEPAD Steering Committee on the surveillance of the health security of medicines and vaccines. This event brought together 21 African countries, including partners such as the Senegalese Minister of Health, the Pharmacy Regulation Agency (ARP), Africa Resource Centre, and international organisations. The initiative, which aims at harmonising legislation, strengthening regional cooperation and raising public awareness, is a key lever for improving health security on the continent. Foulo Basse presented the progress and prospects of the Lomé Initiative, launched in 2020 with six African countries to combat the trafficking of falsified medicines. 

## **Pharmaceutical Week of Benin** 

On 24 and 25 September 2025 in Cotonou, the 12th edition of Benin’s Pharmaceutical Week brought together experts, pharmacists and technical partners around a central issue, the role of pharmacists in ensuring access to essential, quality and affordable medicines. Among the committed actors, the Foundation continued its mission of combating falsified medicines, leading a delegation that included the Togolese team. On this occasion, the Brazzaville Foundation put forward a proposal to create a platform to monitor the recommendations issued during the event to ensure their implementation and 

**6** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Trustees' Annual Report (Incorporating the Director's Report)** _**(continued)**_ 

## **Year ended 31 December 2025** 

follow-up. This engagement follows the Lomé Initiative launched in 2020, which led to the development of national plans to fight falsified medicines in partnership with WHO, WAHO, the Brazzaville Foundation and other donors. Today, the African Medicines Agency (AMA) strengthens this framework by coordinating pharmaceutical regulation at the continental level. 

## **Advocacy and Visibility Outside Africa** 

## • Media engagements. 

A series of interviews with major international media outlets, including Reuters, Forbes and CNBC, increased the visibility of the Lomé Initiative and raised awareness of the health and economic impact of falsified medicines. 

## **Participation in the BESAFE Conference, 2025 edition** 

## • Intervention by the Director-General in Washington. 

In October 2025, Foulo Basse took part in the “BESAFE” forum in Washington, an international gathering dedicated to combating falsified medicines and securing pharmaceutical supply chains. BESAFE brings together experts, health authorities, universities and international organisations to promote solutions for identification, regulation, surveillance and cross-border coordination against falsified medicines. The Foundation’s participation helps anchor the Lomé Initiative within global networks engaged in the fight against falsified medical products. 

## **Development of the Academic Partnership with the Sorbonne** 

## • Advanced preparatory meetings. 

In-depth working sessions were held with representatives of Université Paris 1 Panthéon-Sorbonne in preparation for launching a Chair on “Health and Environment”. 

## • Sponsorship of the next graduating class. 

Jean-Yves Ollivier, as President of the Brazzaville Foundation, will serve as patron of the next graduating class of the Bachelor’s programme in Economics and Finance at Université Paris 1 Panthéon-Sorbonne. The graduation ceremony is scheduled for March 2026. 

**7** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Trustees' Annual Report (Incorporating the Director's Report)** _**(continued)**_ 

## **Year ended 31 December 2025** 

## **Financial review** 

The Foundation received financial contributions from donors and partners of £773,996 (Restated 2024: £713,348) from: 

- ➢ The Republic of Togo contributed to the Foundation's work programme in the development of the Lomé Initiative against falsified and substandard medical products in accordance with the agreement between the two parties. 

- ➢ The Gates Foundation awarded the Foundation with a grant to support the mission on substandard and falsified medicines in Lomé and Dakar as well as specific activities of the initiative. 

The Foundation ended the 2025 year with the balance on the general funds of £251,378 and restricted funds of £75,949, a total of £327,327 (2024: General funds of £222,645, restricted funds £nil, total £222,645). 

During the year, Mr. Olliver claimed expenses totalling £42,988 (2024: Nil). In addition, he personally covered a significant proportion of costs incurred while carrying out work on behalf of the Foundation. In 2025, these personally funded costs amounted to £279,565 (2024: £138,644). 

These amounts have been treated as a pro bono donation within these financial statements. The expenses primarily relate to: 

- Organising forums and meetings for the Foundation 

- Attending forums and various external meetings on behalf of the Foundation 

**8** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Trustees' Annual Report (Incorporating the Director's Report)** _**(continued)**_ 

## **Year ended 31 December 2025** 

## **Plans for future periods** 

## **Implementation of the Lomé Initiative** 

In 2026, the Foundation will keep on developing the Lomé Initiative including accompanying countries in the signature and ratification of the MEDICRIME Convention to ensure effective criminalisation and encouraging other African countries to join. 

The Foundation will continue the method modelling phase before spreading it to further signatory countries. This will include the enrichment of the methodology to develop the national plan to combat substandard and falsified medical product (SFMP). In this case, the collaboration with Senegal is already formalised and started. 

## **Next steps in the partnership with the National Regulatory Agency of Senegal.** 

The Brazzaville Foundation and the Bill and Melinda Gates Foundation (BMGF) agreed to work with Senegal as it is a priority country for BMGF as well. 

Overall Objectives of the Partnership (BF & Senegalese NRA): 

- 1) Lomé Initiative to Senegal 

   - ➢ Share the Lome Initiative experience and help Senegal to build a Senegalese National Plan against fake medicines including communication and training. 

   - ➢ Help and facilitate the relationship between Senegal and MEDICRIME so that Senegal can sign and ratify MEDICRIME 

   - ➢ Help Senegal to standardize the process of authorizing the opening or the decision to close a pharmacy on the basis of real data 

   - ➢ And other subjects to be defined. 

- 2) Senegal to Lomé Initiative member countries 

   - ➢ Share their experience with WHO programs 

   - ➢ Training Lomé Initiative member countries, specifically the new national Regulatory Agency of Togo 

   - ➢ Support the least advanced member countries of the Lome Initiative in the standardization of marketing authorizations for medicines 

   - ➢ And other subjects to be defined. 

## **SF Fund for Quality Medical Products.** 

A proposal, initiated by the Brazzaville Foundation, will explore the creation of a pan-African fund addressing supply chain, storage, distribution and regulatory support for quality medical products. The proposal stems from the Foundation’s direct operational experience under the LoméInitiative and related national pilot projects, notably in Togo, which have highlighted persistent structural weaknesses in medical supply chains and regulatory capacity _._ 

## **Creation of the Brazzaville Foundation Health & Environment Chair** 

The Foundation will continue to advocate and bring the atatnetion of its stakeholders the close links existing between environment and health through its partnership with the Paris 1 Panthéon-Sorbonnes University. The proposal to establish the academic Chair was initiated by the Brazzaville Foundation with the objective of anchoring the Foundation’s work within an academic framework focused on health, environment and governance. 

**9** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Trustees' Annual Report (Incorporating the Director's Report)** _**(continued)**_ 

## **Year ended 31 December 2025** 

The role of this Chair is to encourage the transfer of knowledge, know-how and technologies to African countries, while promoting research. It is aimed at students, researchers and companies (private or public) in the field concerned, in Africa and the West. The Chair is intended to support the development of new and sustainable funding opportunities for the Foundation in furtherance of its charitable purposes. 

The Brazzaville Foundation Health & Environment Chair will focus its activities in three privileged and interdependent areas as follows: 

- ➢ Axis 1): Health, in particular the fight against substandard and falsified medical products (SFMP) and the impacts of climate change and ecosystem degradation on the emergence and prevalence of diseases. 

- ➢ Axis 2) Environment / Climate change - Implications for biodiversity loss, sustainable development, peace and stability: axes aimed at promoting climate resilience and the potential of nature-based solutions. 

- ➢ Axis 3) Transfer of knowledge, know-how and technology to Africa in relevant sectors. 

## **Co-organisation Brazzaville Foundation with Johns Hopkins – BESAFE Conference** 

BESAFE is an initiative led by the Johns Hopkins Bloomberg School of Public Health, bringing together researchers, policymakers and practitioners to address substandard and falsified medical products and strengthen medical product safety and supply chains. Following discussions with the organisers, the Brazzaville Foundation proposed that a future BESAFE Forum session be held in Africa, with the Foundation acting in a coordinating role. The organisers have agreed to this proposal in principle. 

## **Going concern** 

The Trustees have reviewed the ongoing expenditure since the year end, together with the anticipated income and expenses for the next twelve months and are satisfied that it is appropriate to prepare the Foundation's accounts on the going concern basis. 

## **Reserves Policy** 

The Foundation has unrestricted reserves at the end of the reporting period of £251,378 (2024: £222,645). The aim is to maintain and grow the reserves such that the Foundation is holding at least four months' future operating costs. 

**10** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Trustees' Annual Report (Incorporating the Director's Report)** _**(continued)**_ 

## **Year ended 31 December 2025** 

## **Trustees' responsibilities statement** 

The trustees, who are also directors for the purposes of company law, are responsible for preparing the trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). 

Company law requires the charity trustees to prepare financial statements for each year which give a true and fair view of the state of affairs of the charitable company and the incoming resources and application of resources, including the income and expenditure, for that period. 

In preparing these financial statements, the trustees are required to: 

- select suitable accounting policies and then apply them consistently; 

- observe the methods and principles in the applicable Charities SORP; 

- make judgments and accounting estimates that are reasonable and prudent; 

- state whether applicable UK Accounting Standards have been followed, subject to any material 

- departures disclosed and explained in the financial statements, and 

- prepare the financial statements on the going concern basis unless it is inappropriate to presume 

- that the charity will continue in business. 

The trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charity's transactions and disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 

The trustees' annual report was approved on 4 September 2026 and signed on behalf of the board of trustees by: 


76B80000-6A04-A239-F557-08DF16648319 

Mr Philippe Jonnart Trustee 

**11** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Independent Exa miner’s Report to the Members of The Brazzaville Foundation** 

## **Year ended 31 December 2025** 

## **Independent examiner's report to the trustees of The Brazzaville Foundation ('the Company')** 

I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 December 2025. 

## **Responsibilities and basis of report** 

As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act'). 

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act. 

## **Independent examiner's statement** 

Since your charity's gross income exceeded £250,000 your examiner must be a member of a listed body. I can confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies. 

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe: 

1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or 

2. the accounts do not accord with those records; or 

3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or 

4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)). 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. 

**12** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Independent Exa miner’s Report to the Members of The Brazzaville Foundation** 

## **Year ended 31 December 2025** 


76B80000-6A04-A239-F578-08DF16648319 

M Cooper ACA 

Institute of Chartered Accountants in England and Wales 

Hopper Williams & Bell Limited 

Chartered Accountants 

Highland House Mayflower Close Chandler's Ford 

Eastleigh 

Hampshire SO53 4AR 

28/09/2026 

76B80000-6A04-A239-F57A-08DF16648319 Date: . ~~....~~ ....................... ~~...~~ .............. 

**13** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Statement of Financial Activities (including income and expenditure account)** 

## **Year ended 31 December 2025** 

||||||Restated|
|---|---|---|---|---|---|
||||**2025**||2024|
|||Unrestricted|Restricted|||
|||funds|funds|**Total funds**|Total funds|
||**Note**|**£**|**£**|**£**|£|
|**Income and endowments**||||||
|Donations and legacies|**6**|698,047|75,949|773,996|713,348|
|Investment income|**7**|217|–|217|727|
|||--------------------------------|----------------------------|--------------------------------|--------------------------------|
|**Total income**||698,264|75,949|774,213|714,075|
|||================================|============================|================================|================================|
|**Expenditure**||||||
|Expenditure on raising funds:||||||
|Costs of raising donations and||||||
|legacies|**8**|8,126|–|8,126|8,409|
|Expenditure on charitable activities|**9,10**|661,405|–|661,405|505,346|
|||--------------------------------|----------------------------|--------------------------------|--------------------------------|
|**Total expenditure**||669,531|–|669,531|513,755|
|||================================|============================|================================|================================|
|||--------------------------------|----------------------------|--------------------------------|--------------------------------|
|**Net income and net movement in**|**funds**|28,733|75,949|104,682|200,320|
|||================================|============================|================================|================================|
|**Reconciliation of funds**||||||
|Total funds brought forward||222,645|–|222,645|22,325|
|||--------------------------------|----------------------------|--------------------------------|--------------------------------|
|**Total funds carried forward**||251,378|75,949|327,327|222,645|
|||================================|============================|================================|================================|



The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities. 

**The notes on pages 17 to 27 form part of these financial statements.** 

**14** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Statement of Financial Position** 

## **31 December 2025** 

|||**2025**|2024|
|---|---|---|---|
||**Note**|**£**|£|
|**Fixed assets**||||
|Tangible fixed assets|**17**|–|330|
|**Current assets**||||
|Debtors|**18**|272,020|4,851|
|Cash at bank and in hand||111,368|237,801|
|||--------------------------------|--------------------------------|
|||383,388|242,652|
|**Creditors: amounts falling due within one year**|**19**|56,061|20,337|
|||--------------------------------|--------------------------------|
|**Net current assets**||327,327|222,315|
|||----------------------------|--------------------------------|
|**Total assets less current liabilities**||327,327|222,645|
|||----------------------------|--------------------------------|
|**Net assets**||327,327|222,645|
|||============================|================================|
|**Funds of the charity**||||
|Unrestricted funds||251,378|222,645|
|Restricted funds||75,949|-|
|||----------------------------|--------------------------------|
|**Total charity funds**|**21**|327,327<br>============================|222,645<br>================================|



The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025. 

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006. 

The trustees acknowledge their responsibilities for 

(a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and 

(b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company. 

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime. 

These financial statements were approved by the board of trustees and authorised for issue on 4 September 2026, and are signed on behalf of the board by: 


76B80000-6A04-A239-F56A-08DF16648319 

Mr Philippe Jonnart Trustee 

**The notes on pages 17 to 27 form part of these financial statements.** 

**15** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Statement of Cash Flows** 

## **Year ended 31 December 2025** 

||**2025**|2024|
|---|---|---|
||**£**|£|
|**Cash flows from operating activities**|||
|Net (expenditure)/income|104,682|200,320|
|_Adjustments for:_|||
|Depreciation of tangible fixed assets|330|339|
|Other interest receivable and similar income|(217)|(727)|
|Accrued expenses|71,665|4,501|
|_Changes in:_|||
|Trade and other debtors|(267,169)|(2,836)|
|Trade and other creditors|(35,724)|(86,102)|
||--------------------------------|--------------------------------|
|Cash (used in)/generated from operations|(126,650)|115,495|
|Interest received|217|727|
||--------------------------------|--------------------------------|
|Net cash (used in)/from operating activities|(126,433)|116,222|
||================================|================================|
|**Cash flows from investing activities**|||
|Purchase of tangible assets|–|–|
||--------------------------------|--------------------------------|
|Net cash used in investing activities|–|–|
||================================|================================|
|**Net (decrease)/increase in cash and cash equivalents**|(126,433)|116,222|
|**Cash and cash equivalents at beginning of year**|237,801|121,579|
||--------------------------------|--------------------------------|
|**Cash and cash equivalents at end of year**|111,368|237,801|
||================================|================================|



**The notes on pages 17 to 27 form part of these financial statements.** 

**16** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Notes to the Financial Statements** 

## **Year ended 31 December 2025** 

## **1. General information** 

The charity is a public benefit entity and a private company limited by guarantee, registered in England and Wales and a registered charity in England and Wales. The address of the registered office is 36/37 Vintage House, Albert Embankment, London, SE1 7TL. 

## **2. Statement of compliance** 

These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland', the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (Charities SORP (FRS 102) ( effective 1 January 2019) and the Companies Act 2006. 

## **3. Accounting policies** 

## **Basis of preparation** 

The financial statements have been prepared under the historical cost convention. 

The financial statements are prepared in sterling, which is the functional currency of the entity. The amounts are rounded to the nearest pound. 

## **Going concern** 

At the time of approving the accounts the Trustees have a reasonable expectation that the Foundation has adequate resources to continue in operational existence for the foreseeable future. Thus the Trustees continue to adopt the going concern basis of accounting in preparing these accounts. 

## **Judgements and key sources of estimation uncertainty** 

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. 

## Significant judgements 

There are no judgements (apart from those involving estimations) that management has made in the process of applying the entity's accounting policies and that have a significant effect on the amounts recognised in the financial statements. 

Key sources of estimation uncertainty 

Accounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome. There are no key assumptions or other sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year. 

**17** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Notes to the Financial Statements** _**(continued)**_ 

## **Year ended 31 December 2025** 

## **3. Accounting policies** _**(continued)**_ 

## **Foreign currencies** 

Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the statement of financial activities. 

## **Fund accounting** 

Unrestricted funds are available for use at the discretion of the trustees to further any of the charity's purposes. 

Designated funds are unrestricted funds earmarked by the trustees for particular future project or commitment. 

Restricted funds are subjected to restrictions on their expenditure declared by the donor or through the terms of an appeal, and fall into one of two sub-classes: restricted income funds or endowment funds. 

The funds received in the year are considered by the Trustees to be unrestricted and are available for use at the discretion of the Trustees to further any of the charity's purposes.  The Trustees have reviewed the activities of the charity and consider there to be four separate activities in the year (2024: four activities), the work on sub-standard and falsified medicines, partly run through an office in Togo set up for the purpose, work on conflict prevention in Africa, Environmental conservation in in Africa and other programme development including Civil Society support and Europe-Africa dialogue. 

## **Incoming resources** 

All income is included in the statement of financial activities when entitlement has passed to the charity, it is probable that the economic benefits associated with the transaction will flow to the charity and the amount can be reliably measured. 

The charity's income consists of donations receivable. 

The following specific policies are applied to particular categories of income: 

- income from donations is recognised when there is evidence of entitlement to the gift, receipt is probable and its amount can be measured reliably. 

- donated facilities and services are recognised in the accounts when received if the value can be reliably measured. No amounts are included for the contribution of general volunteers. 

**18** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Notes to the Financial Statements** _**(continued)**_ 

## **Year ended 31 December 2025** 

## **3. Accounting policies** _**(continued)**_ 

## **Resources expended** 

Expenditure is incurred in pursuit of the charity's objects of peace and conservation and is recognised on an accruals basis as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered and is classified under headings of the statement of financial activities to which it relates. 

Expenditure on raising funds includes a percentage of the annual Advisory Board costs and of the support costs allocated to the Advisory Board as discussed below. 

Expenditure on charitable activities includes all costs incurred by a charity in undertaking activities that further its charitable aims for the benefit of its beneficiaries, including those support costs and costs relating to the governance of the charity apportioned to charitable activities. 

All costs are allocated to expenditure categories reflecting the use of the resource. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs are apportioned between the activities they contribute to on a reasonable, justifiable and consistent basis. 

## **Operating leases** 

Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis. 

## **Tangible assets** 

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. 

An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other recognised gains and losses, unless it reverses a charge for impairment that has previously been recognised as expenditure within the statement of financial activities.  A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other recognised gains and losses, except to which it offsets any previous revaluation gain, in which case the loss is shown within other recognised gains and losses on the statement of financial activities. 

## **Depreciation** 

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows: 

Equipment - 33% straight line 

**19** 



## **The Brazzaville Foundation** 

## **Company Limited by Guarantee** 

## **Notes to the Financial Statements** _**(continued)**_ 

## **Year ended 31 December 2025** 

## **3. Accounting policies** _**(continued)**_ 

## **Impairment of fixed assets** 

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. 

For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. 

## **Financial instruments** 

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. 

Basic financial instruments are initially recognised at the amount receivable or payable including any related transaction costs, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. 

Current assets and current liabilities are subsequently measured at the cash or other consideration expected to be paid or received and not discounted. 

Debt instruments are subsequently measured at amortised cost. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised under the appropriate heading in the statement of financial activities in which the initial gain was recognised. 

Any reversals of impairment are recognised immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised. 

## **Defined contribution plans** 

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. 

**20** 



When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as an expense in the period in which it arises. 

## **4. Prior Period Adjustment** 

During the year, it was identified that a gift in kind received in the year ended 31 December 2024 had not been recognised in the financial statements. The gift in kind met the recognition criteria of the Charities SORP (FRS 102) and a reliable estimate of its value was available at that time. 

Accordingly, the comparative figures have been restated to recognise donation income of £58,400 together with the related charitable expenditure of £58,400. The adjustment has no effect on the previously reported net movement in funds, total funds or net assets of the charity. 

Comparative figures throughout the financial statements have been amended to reflect this adjustment. 

## **5.  Limited by guarantee** 

The Brazzaville Foundation is incorporated as a company limited by guarantee not having any share capital. 

## **6. Donations and legacies** 

||Unrestricted|Restricted|**Total Funds**|
|---|---|---|---|
||Funds|Funds|**2025**|
||£|£|**£**|
|**Donations**||||
|Donations non-UK|698,264|75,949|773,996|
||================================|============================|================================|
||||Total Funds|
||Unrestricted|Restricted|Restated|
||Funds|Funds|2024|
||£|£|£|
|**Donations**||||
|Donations non-UK|713,348|-|713,348|
||================================|============================|================================|



## **7. Investment income** 

||Unrestricted|**Total Funds**|Unrestricted|Total Funds|
|---|---|---|---|---|
||Funds|**2025**|Funds|2024|
||£|**£**|£|£|
|Bank interest receivable|217|217|727|727|
||==============|==============|==============|==============|



**21** 



## **8. Costs of raising donations and legacies** 

|Unrestricted|**Total Funds**|Unrestricted|Total Funds|
|---|---|---|---|
|Funds|**2025**|Funds|2024|
|£|**£**|£|£|
|8,126<br>============================|8,126<br>============================|8,409<br>============================|8,409<br>============================|



Support costs have been allocated to Fundraising on a time spent basis. 

As in 2024 no Advisory Board meeting took place but the Foundation informed the members of the Advisory Board on a regular basis. 

## **9. Expenditure on charitable activities by fund type** 

||Unrestricted|Restricted|**Total Funds**|
|---|---|---|---|
||Funds|Funds|**2025**|
||£|£|**£**|
|Sub-standard and falsified medicines & Youth||||
|Engagement|209,615|–|209,615|
|Civil Society Support and other Programme||||
|Development|280,990|–|280,990|
|Support costs|170,800|–|170,800|
||--------------------------------|----------------------------|--------------------------------|
||661,405|–|661,405|
||================================|============================|================================|
||||Total Funds|
||Unrestricted|Restricted|Restated|
||Funds|Funds|2024|
||£|£|£|
|Sub-standard and falsified medicines & Youth||||
|Engagement|159,658|–|159,658|
|Conflict Prevention|1,395|–|1,395|
|Environmental Conservation|1,322|–|1,322|
|Civil Society Support and other Programme||||
|Development|197,963|–|197,963|
|Support costs|145,008|–|145,008|
||--------------------------------|--------------|--------------------------------|
||503,346|–|503,346|
||================================|============================|================================|



## **10. Expenditure on charitable activities by activity type** 

||Activities|||Total Funds|
|---|---|---|---|---|
||undertaken|Support|**Total Funds**|Restated|
||directly|costs|**2025**|2024|
||£|£|**£**|£|
|Sub-standard and falsified medicines|||||
|& Youth Engagement|209,615|87,266|296,881|227,695|
|Conflict Prevention|–|–|–|1,395|
|Environmental Conservation|–|–|–|1,322|
|Civil Society Support and other|||||
|Programme Development|280,990|69,154|350,144|251,881|
|Governance costs|–|14,380|14,380|23,053|
||--------------------------------|--------------------------------|--------------------------------|--------------------------------|
||490,605|170,800|661,405|503,346|
||================================|================================|================================|================================|



Governance and support costs exclude costs of £756 (2024; £1,213) attributed to costs of raising donations. 

**22** 



## **11. Analysis of support costs** 

|||||Civil|||
|---|---|---|---|---|---|---|
|||||Society|||
||Sub-|||Support|||
||standard|||and other|||
||and falsified|Conflict|<br>Environmental|Program|||
||medicines|Prevention|<br>Conservation|Dev.|**Total 2025**|Total 2024|
||£|£|£|£|**£**|£|
|Staff costs|14,893|-|<br>-|11,802|26,696|31,381|
|Premises|452|-|<br>-|358|809|17,704|
|Communications|||||||
|and IT|1,032|-|<br>-|818|1,850|3,753|
|General office|17,758|-|<br>-|14,073|31,831|13,219|
|Finance costs|2,931|-|<br>-|2,323|5,254|7,818|
|Governance|||||||
|costs|8,023|-|<br>-|6,358|14,380|23,053|
|Professional fees|646|-|<br>-|512|1,158|10,217|
|Marketing & PR|49,754|-|<br>-|39,428|89,182|28,410|
|Foreign exchange|||||||
|costs|(201)|-|<br>-|(159)|(360)|9,453|
||--------------------------------|----------------------------|----------------------------|----------------------------|----------------------------|--------------------------------|
||95,288|-|<br>-|75,512|170,800|145,008|
||================================|============================|============================|============================|================================|================================|



In the year ended 31 December 2025, the charity mainly concentrated its work on sub-standard and falsified medical medicines by Lomé initiative. The cost accounting system developed in 2020 allows recording the costs of different activities more accurately and has enabled salaries to be directly allocated to an activity on a monthly basis. 

Support costs have then been allocated to charitable activities in accordance with the hours spent on that activity in the period.  The Trustees have agreed that the use of hours spent better reflects the true allocation of costs. 

The costs donated by Mr Ollivier are omitted from the calculations to attribute support costs as the Trustees do not consider the support costs incurred by the Foundation relevant to the activities directly organised and paid for by Mr Ollivier. 

## **12. Net (expenditure)/income** 

Net (expenditure)/income is stated after charging/(crediting): 

||Net (expenditure)/income is stated after charging/(crediting):|||
|---|---|---|---|
|||**2025**|2024|
|||**£**|£|
||Depreciation of tangible fixed assets|330|1,638|
||Foreign exchange differences|567|6,888|
|||============================|============================|
|**13.**|**Independent examiner's and** **Auditor’s remuneration**|||
|||**2025**|2024|
|||**£**|£|
||Fees payable for the independent examination of the financial|||
||statements|4,000|-|
||Fees payable for the audit of the financial statements|-|9,504|
|||============================|============================|



**23** 



## **14. Staff costs** 

The total staff costs and employee benefits for the reporting period are analysed as follows: 

|||Restated|
|---|---|---|
||**2025**|2024|
||**£**|£|
|Wages and salaries|95,000|111,968|
|Social security costs|12,195|9,981|
|Employer contributions to pension plans|2,663|2,735|
||--------------------------------|--------------------------------|
||109,858<br>================================|124,684<br>================================|



The average head count of employees during the year was 2 (2024: 2). The average number of full-time equivalent employees during the year is analysed as follows: 

||**2025**|2024|
|---|---|---|
||**No.**|No.|
|Number of staff - Administration|1|1|
|Number of staff - Charitable activities|1|1|
||--------------|--------------|
||2|2|
||==============|==============|
|The number of employees whose remuneration for the year fell within the following bands, were:|||
||**2025**|2024|
||**No.**|No.|
|£60,000 to £69,999|1|0|
||==============|==============|



## **Key Management Personnel** 

Key management personnel include all persons that have authority and responsibility for planning, directing and controlling the activities of the charity. Throughout 2025 and for 10 months of 2024 the Chief Executive Officer (CEO) worked on a pro bono basis. As his salary can be reliably estimated it has been included in the accounts as a gift-in-kind along with relevant employment tax and savings. 

## **15. Trustee remuneration and expenses** 

No remuneration or other benefits from employment with the charity or a related entity were received by the trustees except as outlined in Note 25. 

**24** 



## **16. Statement of financial activities - year ended 31 December 2024** 

||||**2024** **Restated**|**2024** **Restated**||
|---|---|---|---|---|---|
|||Unrestricted|Restricted|||
|||funds|funds|**Total funds**||
|||**£**|**£**||**£**|
||**Income and endowments**|||||
||Donations and legacies|713,348|–|713,348||
||Investment income|727|–||727|
|||--------------------------------|----------------------------|--------------------------------||
||**Total income**|714,075|–|714,075||
|||================================|============================|================================||
||**Expenditure**|||||
||Expenditure on raising funds:|||||
||Costs of raising donations and|||||
||legacies|8,409|–|<br>8,409||
||Expenditure on charitable activities|505,346|–|<br>505,346||
|||--------------------------------|----------------------------|--------------------------------||
||**Total expenditure**|513,755|–|<br>513,755||
|||================================|============================|================================||
|||--------------------------------|----------------------------|--------------------------------||
||**Net (expenditure)/income and net**|||||
||**movement in funds**|200,320|–|<br>200,320||
|||================================|============================|================================||
||**Reconciliation of funds**|||||
||Total funds brought forward|22,325|–|<br>22,325||
|||--------------------------------|----------------------------|--------------------------------||
||**Total funds carried forward**|222,645|–|<br>222,645||
|||================================|============================|================================||
|**17.**|**Tangible fixed assets**|||||
||||||**Equipment**|
||||||**£**|
||**Cost**|||||
||**At 1 January 2025 and 31 December 2025**||||1,018|
||||||============================|
||**Depreciation**|||||
||At 1 January 2025||||<br>(687)|
||Charge for the year||||(330)|
||||||----------------------------|
||**At 31 December 2025**||||–|
||||||============================|
||**Carrying amount**|||||
||**At 31 December 2025**||||–|
||||||============================|
||At 31 December 2024||||330|
||||||============================|
|**18.**|**Debtors**|||||
|||||**2025**|2024|
|||||**£**|£|
||Prepayments and accrued income|||2,508|<br>2,345|
||Other debtors|||269,511|<br>2,345|
|||||--------------------------------|-----------------------|
|||||272,020|<br>4,780|
|||||================================|=======================|



**25** 



## **19. Creditors: amounts falling due within one year** 

||**2025**|2024|
|---|---|---|
||**£**|£|
|Trade creditors|-|279|
|Accruals and deferred income|54,433|20,058|
|Social security and other taxes|1,628|–|
||--------------------------------|--------------------------------|
||56,061|20,337|
||================================|================================|



## **20. Pensions and other retirement benefits** 

## **Defined contribution plans** 

The amount recognised in income or expenditure as an expense in relation to defined contribution plans was £2,815 (2024: £2,815). 

## **21. Analysis of charitable funds** 

||At|||**At**|
|---|---|---|---|---|
||1 Jan 2025|Income|Expenditure|**31 Dec 2025**|
||£|£|£|£|
|**Unrestricted funds**|||||
|General funds|222,645|698,264|(669,531)|<br>251,378|
||================================|================================|================================|============================|
|**Restricted funds**|||||
|Substandard and Falsified Medicines|||||
|in Africa|-|75,949|-|75,949|
||================================|================================|================================|============================|
|**Total funds**|222,645|774,213|(669,532)|327,327|
||================================|================================|================================|================================|
||At|||At|
||1 Jan 2024|Income|Expenditure|31 Dec 2024|
||£|£|£|£|
|**Unrestricted funds**|||||
|General funds|22,325|714,075|(513,755)|<br>222,645|
||============================|================================|================================|================================|



## **Restricted funds** 

Substandard and Falsified Medicine in Africa (SF Fund): A donation was received for the support of a structured six-month workplan extension taking place throughout 2026. 

**26** 



## **22. Analysis of net assets between funds** 

||Unrestricted|Restricted|**Total Funds**|
|---|---|---|---|
||Funds|Funds|**2025**|
||£|£|**£**|
|Tangible fixed assets|–|–|–|
|Current assets|304,980|75,949|380,929|
|Creditors less than 1 year|(53,602)|–|(53,602)|
||--------------------------------|--------------------------------|--------------------------------|
|**Net assets**|251,378|75,949|327,327|
||================================|================================|================================|
||Unrestricted|Restricted|Total Funds|
||Funds|Funds|2024|
||£|£|£|
|Tangible fixed assets|330|–|330|
|Current assets|242,653|–|242,653|
|Creditors less than 1 year|(20,337)|–|(20,337)|
||--------------------------------|--------------------------------|--------------------------------|
|**Net assets**|222,645<br>================================|–<br>================================|222,645<br>================================|



## **23. Financial instruments** 

The carrying amount for each category of financial instrument is as follows: 

||**2025**|2024|
|---|---|---|
||**£**|£|
|**Financial assets that are debt instruments measured at amortised**|**cost**||
|Financial assets that are debt instruments measured at amortised|||
|cost|267,125|4,781|
||=======================|=======================|
|**Financial liabilities measured at amortised cost**|||
|Financial liabilities measured at amortised cost|53,602|19,395|
||============================|============================|
|**Loan commitments measured at cost less impairment**|||
|Loan commitments measured at cost less impairment|–|–|
||============================|============================|



## **24. Analysis of changes in net debt** 

|||At||**At**|
|---|---|---|---|---|
||1|Jan 2025|Cash flows|**31 Dec 2025**|
|||£|£|**£**|
|Cash at bank and in hand||237,801|(126,433)|<br>111,368|
|||================================|================================|================================|



## **25. Related parties** 

Mr Jean-Yves Ollivier remains a significant donor to The Brazzaville Foundation in the year. The amounts donated by Mr Ollivier in the year were £279,565 (2024: £138,644) 

Mr Olliver claimed expenses of £42,688 during the year (2024: Nil). No remuneration was paid to any Trustees, nor did any Trustee receive benefits from the charity. 

**27** 



Document electronically signed www.fusesign.com 


## Document Details 

|Document ID|a1bc0000-7d5d-2215-b965-08df1660f42e|
|---|---|
|Document bundle ID|e7fb0000-d70f-7ac8-87ab-08df1660f7c7|
|Uploaded to FuseSign|2026-09-19 16:16 +01:00|
|FuseSign subscriber|HWB Accountants|
|Initiator email|cohan.lewis@hwb-accountants.com|
|||
|Document completed|2026-09-28 16:37 +01:00|



## Document Signers 

|Name<br>Philippe Jonnart<br>Email<br>philippejonnart@gmail.com<br>Mobile<br>Not Provided<br>IP Address/es<br>78.196.172.221<br>Signed on Pages<br>13, 17<br>Verification Mode<br>Email Code||
|---|---|
|||
|Name<br>Matt Cooper<br>Email<br>matt.cooper@hwb-accountants.com<br>Mobile<br>Not Provided<br>IP Address/es<br>51.11.144.21<br>Signed on Pages<br>15<br>Verification Mode<br>No 2FA||



## Document Audit Log 

|Date|||User|Transaction|
|---|---|---|---|---|
|2026-09-19|16:41|+01:00|cohan.lewis@hwb-accountants.com|Document Bundle Created by Cohan Lewis (cohan.lewis@hwb-|
|||||accountants.com)|
|2026-09-19|16:41|+01:00|System|Access link: sending email to: philippejonnart@gmail.com. (3|
|||||Documents - 2 Signing Actions).|
|2026-09-21|13:24|+01:00|Philippe Jonnart|Email Verification Requested to email philippejonnart@gmail.com|
|2026-09-21|13:25|+01:00|Philippe Jonnart|Code entered and verified|
|2026-09-21|13:25|+01:00|Philippe Jonnart|Link opened from IP 78.196.172.221|



Document electronically signed by FuseSign Document ID: a1bc0000-7d5d-2215-b965-08df1660f42e 



|2026-09-21|13:26|+01:00|Philippe Jonnart|Document Signed: A4 Final BF Accounts YE Dec 2025 [FYI-|
|---|---|---|---|---|
|||||184051747].pdf - on page 13 (SignatureID: 76b80000-6a04-a239-|
|||||f557-08df16648319, SignatureType: SignedByName)|
|2026-09-21|13:26|+01:00|Philippe Jonnart|Document Signed: A4 Final BF Accounts YE Dec 2025 [FYI-|
|||||184051747].pdf - on page 17 (SignatureID: 76b80000-6a04-a239-|
|||||f56a-08df16648319, SignatureType: SignedByName)|
|2026-09-21|13:26|+01:00|Philippe Jonnart|Document Signed: A4 Final BF Accounts YE Dec 2025 [FYI-|
|||||184051747].pdf (SignatureType: SignedByName)|
|2026-09-21|13:26|+01:00|Philippe Jonnart|Philippe Jonnart has completed bundle e7fb0000-d70f-7ac8-87ab-|
|||||08df1660f7c7|
|2026-09-21|13:26|+01:00|System|Progressing bundle to signing group 2|
|2026-09-21|13:26|+01:00|System|Access link: sending email to: matt.cooper@hwb-accountants.com.|
|||||(3 Documents - 1 Signing Action).|
|2026-09-28|16:33|+01:00|Matt Cooper|Customer verified by unique URL sent via Email (no 2FA)|
|2026-09-28|16:33|+01:00|Matt Cooper|Customer verified by unique URL sent via Email (no 2FA)|
|2026-09-28|16:34|+01:00|Matt Cooper|Customer verified by unique URL sent via Email (no 2FA)|
|2026-09-28|16:34|+01:00|Matt Cooper|Link opened from IP 51.11.144.21|
|2026-09-28|16:37|+01:00|Matt Cooper|Document Signed: A4 Final BF Accounts YE Dec 2025 [FYI-|
|||||184051747].pdf - on page 15 (SignatureID: 76b80000-6a04-a239-|
|||||f578-08df16648319, SignatureType: SignedByName)|
|2026-09-28|16:37|+01:00|Matt Cooper|Form fields submitted for document: A4 Final BF Accounts YE Dec|
|||||2025 [FYI-184051747].pdf|
|2026-09-28|16:37|+01:00|Matt Cooper|Document Signed: A4 Final BF Accounts YE Dec 2025 [FYI-|
|||||184051747].pdf (SignatureType: SignedByName)|
|2026-09-28|16:37|+01:00|Matt Cooper|Matt Cooper has completed bundle e7fb0000-d70f-7ac8-87ab-|
|||||08df1660f7c7|
|2026-09-28|16:37|+01:00|System|Progressing bundle to signing group 3|



## More Information 

For more information on electronic signatures and to validate this document was signed by the parties listed above, please visit www.fusesign.com. 

To verify your document, visit: https://app.fuse.work/fusesign/verify/a1bc0000-7d5d-2215-b965-08df1660f42e 

Document electronically signed by FuseSign Document ID: a1bc0000-7d5d-2215-b965-08df1660f42e 

